![]() |
市場調查報告書
商品編碼
1324357
到 2030 年手術縫線市場預測:按產品類型、材料、原料、塗層、用途、最終用戶和地區進行的全球分析Surgical Sutures Market Forecasts to 2030 - Global Analysis By Product Type, Material, Raw Material, Coating, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球手術縫線市場規模為 48.8 億美元,預計在預測期內將以 7.8% 的年複合成長率成長,到 2030 年達到 82.5 億美元。
手術縫合線是一種醫療設備,用於在手術或受傷後閉合傷口並將身體組織連接在一起。通常使用附有線的針來縫合縫線。使用的縫合線類型取決於傷口的特徵和位置。醫療專業人員會考慮線的拉伸強度、材料、可操作性和彈性,以便成功連接組織。
據世界衛生組織(WHO)統計,截至2020年2月,大約有2000萬至5000萬人遭受非致命傷害,其中一些導致骨折,需要進行踝關節置換術和其他骨手術。我不斷收到這種情況。
膝關節關節重建、髖關節置換術、子宮切除術、搭橋手術和整容手術的增加增加了這種設備的使用,以更快地閉合傷口。此外,由於老年人進行關節關節重建和器官移植等外科手術的頻率不斷增加,對外科縫合線的需求和使用正在迅速增加。因此,世界各地的醫療機構需要更先進的設備。
研究人員正在開發新技術並增加微創手術的數量,以造福患者。微創手術比開放性手術便宜,效果更好,並且需要的住院時間更短。這些因素推動了微創手術的接受並限制了市場的擴張。
新興國家人口對現代醫療設施的需求迅速成長,推動了手術縫合線市場的發展。尖端工具和技術的快速擴散正在將市場推向新的高度。潛在客戶被醫療保健系統用於縫合傷口的先進設備所吸引,隨著時間的推移幫助市場產生巨額利潤。
缺乏合格的外科醫生和手術縫合線的高價格阻礙了市場的擴張。可能對市場擴張產生負面影響的另一個重大風險是假冒手術縫線的出現以及手術縫線核准和商業化的嚴格規定。
COVID-19 對全球經濟產生了負面影響。 2020年,許多市場參與企業注意到了下降。疫情期間,許多國家政府推遲了擇期手術,以節省醫療資源以應對 COVID-19 緊急情況。這迫使許多市場參與企業和研究機構推遲與其他慢性病相關的項目。然而,隨著近期新型冠狀病毒肺炎 (COVID-19) 在英國和印度等國家的傳播,推遲手術的趨勢預計將進一步加劇並影響這些設備的採用。
預計縫合線細分市場在預測期內將佔據最大的市場佔有率。這是醫療保健行業巨大需求的結果。手術線是許多醫療保健領域首選的傷口縫合方法,因為它們價格實惠且可供公眾使用。
由於各種冠狀動脈疾病、心律失常患病率的增加增加了搭橋手術的需求以及手術縫合線的使用增加,預計心血管手術領域在預測期內將以最高的年複合成長率成長。最複雜和危險的外科手術涉及心血管系統,因此需要最好、最合適的縫合線。此外,由於心臟病患者數量的增加而導致的心血管手術數量的增加也增加了手術縫合線的市場需求。
由於本地和大型企業的存在、縫合線成本高於其他地區、有利的報銷環境、不斷擴大的政府舉措和醫療保健系統,北美地區在手術縫合線市場佔據主導地位。預計該領域將繼續由技術日益複雜。北美地區高銷售佔有率的主要要素是該地區的高所得和技術進步。
預計亞太地區將在預測期內實現最高成長。這是由於人口高齡化導致更有可能接受手術,以及政府增加醫療保健系統支出以解決該領域未滿足的需求。亞太地區的主要市場包括中國、印度和日本。印度、新加坡和馬來西亞等國家醫療旅遊的興起也是推動該地區市場呈指數級成長的關鍵要素。
According to Stratistics MRC, the Global Surgical Sutures Market is accounted for $4.88 billion in 2023 and is expected to reach $8.25 billion by 2030 growing at a CAGR of 7.8% during the forecast period. A surgical suture is a piece of medical equipment used to close wound edges after surgery or injury and hold body tissues together. Usually, a needle with a thread attached is used to apply it. The characteristics and location of the wound determine which suture should be used. Medical professionals take into account the thread's tensile strength, material, operator friendliness, and elasticity to hold tissues together successfully.
According to the World Health Organization (WHO), till February 2020, around 20-50 million people suffered from non-fatal injuries, of which some resulted in bone fractures, and have consecutively undergone ankle arthroplasty and other bone surgeries.
The use of this device to close wounds more quickly is increasing due to the rise in knee replacements, hip replacements, hysterectomy, bypass surgeries, and cosmetic surgeries. Additionally, the demand for and use of surgical sutures is being increased by the rapidly growing elderly population as a result of the rising frequency of surgical procedures like joint replacement, angioplasty, and organ transplant among elderly patients. This is causing healthcare facilities all over the world to demand more advanced devices.
Researchers are developing new technologies for patients' benefit, which has increased the number of minimally invasive procedures. These procedures are more affordable than open surgeries, offer better results, and require shorter hospital stays. These elements have boosted the acceptance of minimally invasive procedures, which limits the market's expansion.
The market for surgical sutures has been helped by the developing world's population's rapid demand for modern medical facilities. The rapid adoption of cutting-edge tools and technologies by the populace has propelled the market to new heights. Potential customers have been drawn to the sophisticated equipment that the healthcare system uses to suture wounds, which has helped the market generate sizable profits over time.
The market's expansion is hampered by the scarcity of qualified surgeons and the high price of surgical sutures. Another significant risk that could have a negative effect on the market's expansion is the availability of fake surgical sutures and the strict rules governing the approval and commercialization of surgical sutures.
COVID-19 had an adverse impact on the world economy. In 2020, many significant market participants noticed a decline. During the pandemic, the governments of many nations postponed elective surgeries in order to preserve healthcare resources for the COVID-19 emergency. Along with this, the imposition of lockdown forced a number of market participants and research organizations to delay their projects related to other chronic diseases. However, it is anticipated that the recent spread of the new COVID-19 strain in nations like the U.K., India, and others will further the trend of delaying operations and have an impact on the adoption of these devices.
The sutures segment is predicted to hold the largest market share in the estimated timeframe. This is a result of the enormous demand in the healthcare sector. Due to their affordability and ability to be used by the average person, surgical threads have been the preferred method of wound closure in many healthcare sectors.
Due to the increasing prevalence of various coronary artery diseases, arrhythmias, which increase the need for bypass surgeries, and increased use of surgical sutures, the cardiovascular surgery segment is anticipated to grow at the highest CAGR during the projection period. The most complicated and dangerous surgical procedures involve the cardiovascular system, making the best and most appropriate sutures necessary. Additionally, the increased use of cardiovascular surgeries as a result of an increase in patients with heart disorders increases market demand for surgical sutures.
North American region dominated the surgical suture market, and it is predicted to continue dominating the sector due to the presence of local and major players, the high cost of sutures relative to other regions, the favorable reimbursement environment, the expansion of government initiatives, and the sophistication of the healthcare system. The major drivers of North America's significant revenue share include domestically high income and technological advancements in this region.
During the forecast period, Asia Pacific is anticipated to experience the highest growth. This is due to the aging population that is more likely to undergo surgery, as well as an increase in government spending on the healthcare system to address the unmet needs in this area. Major markets in the Asia Pacific region include China, India, and Japan. Another important factor propelling the market in this region toward exponential growth is the rise of medical tourism in nations like India, Singapore, and Malaysia.
Some of the key players profiled in the Surgical Sutures Market include: Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Boston Scientific Corporation, CONMED Corporation, CPT Sutures, Deme TECH Corporation, Derma Sciences, Dolphin Sutures, Ethicon US, LLC. (Johnson & Johnson Services, Inc.), Healthium MedTech, Integra Lifesciences, Internacional farmaceutica, Lotus Surgicals, Medtronic Plc , Mellon Medical B.V., Peter Surgical, Smith & Nephew, Stryker Corporation, Surgical Specialties Corporation, Sutcon Sutures, Vital Sutures and Zimmer Biomets.
In July 2023, Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) approval for the Vercise™ Neural Navigator 5 Software, which when used as part of the Vercise Genus™ Deep Brain Stimulation (DBS) Systems, can provide clinicians with simple and actionable data for efficient programming in the treatment of people living with Parkinson's disease or essential tremor.
In August 2022, CONMED Corporation (announced that it has completed its previously announced acquisition of privately-held Biorez, Inc. The transaction is being financed through the Company's existing credit facility.
In March 2022, B. Braun acquires Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates. With the full integration of Intermedt Medizin & Technik GmbH into the Group, B. Braun has completed the extensive product portfolio of its B. Braun Avitum division as a systems provider for extracorporeal blood treatment (dialysis).
Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa Regions are also represented in the same manner as above.